Bank of America
GOSS icon

Bank of America’s Gossamer Bio GOSS Stock Holding History

Bank of America’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.1K Sell
396,727
-2,776,998
-87% -$775K ﹤0.01% 5571
2026
Q1 		$1.04M Buy
3,173,725
+1,267,056
+66% +$1.99M ﹤0.01% 4505
2025
Q4 		$5.91M Sell
1,906,669
-975,235
-34% -$2.78M ﹤0.01% 3256
2025
Q3 		$7.58M Buy
2,881,904
+2,814,824
+4,196% +$6.2M ﹤0.01% 3593
2025
Q2 		$82.5K Sell
67,080
-96,750
-59% -$106K ﹤0.01% 6613
2025
Q1 		$180K Buy
163,830
+79,042
+93% +$91.4K ﹤0.01% 6233
2024
Q4 		$76.6K Buy
84,788
+43,866
+107% +$37.6K ﹤0.01% 6514
2024
Q3 		$40.3K Sell
40,922
-1,365
-3% -$1.31K ﹤0.01% 6603
2024
Q2 		$38.1K Sell
42,287
-77,679
-65% -$58.1K ﹤0.01% 6586
2024
Q1 		$142K Buy
119,966
+38,261
+47% +$42.1K ﹤0.01% 6070
2023
Q4 		$74.5K Sell
81,705
-14,861
-15% -$11K ﹤0.01% 6485
2023
Q3 		$80.3K Sell
96,566
-7,315
-7% -$8.43K ﹤0.01% 6335
2023
Q2 		$125K Sell
103,881
-125,049
-55% -$156K ﹤0.01% 6105
2023
Q1 		$288K Sell
228,930
-2,814,377
-92% -$5.39M ﹤0.01% 5729
2022
Q4 		$6.6M Buy
3,043,307
+2,685,828
+751% +$22.1M ﹤0.01% 3123
2022
Q3 		$4.28M Sell
357,479
-95,343
-21% -$1.18M ﹤0.01% 3493
2022
Q2 		$3.79M Buy
452,822
+154,855
+52% +$1.2M ﹤0.01% 3694
2022
Q1 		$2.59M Buy
297,967
+44,312
+17% +$427K ﹤0.01% 4333
2021
Q4 		$2.87M Buy
253,655
+160,180
+171% +$1.9M ﹤0.01% 4199
2021
Q3 		$1.18M Buy
93,475
+20,005
+27% +$184K ﹤0.01% 4917
2021
Q2 		$597K Sell
73,470
-69,991
-49% -$607K ﹤0.01% 5282
2021
Q1 		$1.33M Buy
143,461
+69,136
+93% +$697K ﹤0.01% 4592
2020
Q4 		$719K Buy
74,325
+1,246
+2% +$12.3K ﹤0.01% 4757
2020
Q3 		$907K Buy
73,079
+33,398
+84% +$443K ﹤0.01% 4295
2020
Q2 		$516K Buy
39,681
+1,995
+5% +$25.1K ﹤0.01% 4591
2020
Q1 		$383K Sell
37,686
-7,690
-17% -$100K ﹤0.01% 4698
2019
Q4 		$709K Buy
45,376
+23,367
+106% +$471K ﹤0.01% 4758
2019
Q3 		$369K Buy
22,009
+3,474
+19% +$69.1K ﹤0.01% 5285
2019
Q2 		$412K Buy
18,535
+15,882
+599% +$304K ﹤0.01% 5191
2019
Q1 		$58K Buy
+2,653
New +$55.3K ﹤0.01% 6131

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Bank of America's GOSS Position: Q2 2026 in Review

Bank of America reduced its Gossamer Bio (GOSS) stake by 87% in Q2 2026, selling an estimated $775K and leaving 396,727 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5571.

Bank of America first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $7.58M in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Bank of America held 396,727 shares of Gossamer Bio worth $65.1K as of Q2 2026.
  • Bank of America sold 2,776,998 Gossamer Bio shares in Q2 2026, an estimated $775K.
  • Gossamer Bio made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5571 holding.
  • Bank of America first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Bank of America's Gossamer Bio position peaked at $7.58M in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.